ConductScience.org, home

Paper41209019

Osteosarcoma immunometabolism: emerging mechanisms and clinical implications.

Tan B and 1 other. Front Immunol, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Osteosarcoma immunometabolism: emerging mechanisms and clinical implications. Papers, record 41209019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41209019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Osteosarcoma immunometabolism: emerging mechanisms and clinical implications.
PubMed
Journal
Front Immunol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.87, provisional
iCite
Revised in PubMed
2025-11-12
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tan BBowen
2Ning JJingyuan

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OsteosarcomaMajor topic
Tumor MicroenvironmentMajor topic
Bone NeoplasmsMajor topic
Energy MetabolismMajor topic
Humans
Immunotherapy
Animals

Source PubMed

Download CSV of topics

References157

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135461343ANGPTL4 negatively regulates the progression of osteosarcoma by remodeling branched-chain amino acid metabolism.Cell Death Discov2022https://conductscience.org/library/papers/35461343PubMed
238486485FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.Cancer Res2024https://conductscience.org/library/papers/38486485PubMed
337528150NUCKS1, a LINC00629-upregulated gene, facilitated osteosarcoma progression and metastasis by elevating asparagine synthesis.Cell Death Dis2023https://conductscience.org/library/papers/37528150PubMed
430914826Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.Nat Rev Clin Oncol2019https://conductscience.org/library/papers/30914826PubMed
537605057Glutarate regulates T cell metabolism and anti-tumour immunity.Nat Metab2023https://conductscience.org/library/papers/37605057PubMed
639154340Inherent preference for polyunsaturated fatty acids instigates ferroptosis of Treg cells that aggravates high-fat-diet-related colitis.Cell Rep2024https://conductscience.org/library/papers/39154340PubMed
730151352Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy.Front Oncol2018https://conductscience.org/library/papers/30151352PubMed
837209607Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis.Phytomedicine2023https://conductscience.org/library/papers/37209607PubMed
940154215Ultra-sensitive detection of melanoma NRAS mutant ctDNA based on programmable endonucleases.Cancer Genet2025https://conductscience.org/library/papers/40154215PubMed
1030338824Significance of neoadjuvant chemotherapy (NACT) in limb salvage treatment of osteosarcoma and its effect on GLS1 expression.Eur Rev Med Pharmacol Sci2018https://conductscience.org/library/papers/30338824PubMed
1136462545Fatty acid transport proteins (FATPs) in cancer.Chem Phys Lipids2023https://conductscience.org/library/papers/36462545PubMed
1233580363Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.Cancer Immunol Immunother2021https://conductscience.org/library/papers/33580363PubMed
1333503424Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma.Cell Rep2021https://conductscience.org/library/papers/33503424PubMed
1428604752Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells.Oncogene2017https://conductscience.org/library/papers/28604752PubMed
1529176561HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.Nat Commun2017https://conductscience.org/library/papers/29176561PubMed
1636814318Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.J Orthop Surg Res2023https://conductscience.org/library/papers/36814318PubMed
1733589820Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.Nature2021https://conductscience.org/library/papers/33589820PubMed
1818775299Cancer cell metabolism: Warburg and beyond.Cell2008https://conductscience.org/library/papers/18775299PubMed
1938025952A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients.J Transl Int Med2023https://conductscience.org/library/papers/38025952PubMed
2037304579Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma.Mater Today Bio2023https://conductscience.org/library/papers/37304579PubMed

See all 157 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42953799Metabolic State Machines and Nutritional Ecology: A New Framework for Osteosarcoma Therapy.Drug Des Devel Ther2026https://conductscience.org/library/papers/42953799PubMed
42745749Metabolic reprogramming-related drug resistance in osteosarcoma: from molecular mechanisms to therapeutic translation.Front Mol Biosci2026https://conductscience.org/library/papers/42745749PubMed
42681084Identification of a metastasis-associated prognostic gene signature in osteosarcoma through integrated bioinformatics and functional analysis.Mamm Genome2026https://conductscience.org/library/papers/42681084PubMed
42454278Re-Arming the Immunological Radar: The Translational Landscape of Dendritic Cell-Centric Nanotherapeutics and Microenvironment Remodeling for Osteosarcoma.Int J Nanomedicine2026https://conductscience.org/library/papers/42454278PubMed
42143177Machine learning-based integrative analysis identifies CXCL13-driven tertiary lymphoid structures as favorable immune and prognostic features in osteosarcoma.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/42143177PubMed
41953014Immune exclusion as a recurrent immune-escape state driving treatment resistance in osteosarcoma: insights from single-cell, spatial, and multi-omics studies.Front Immunol2026https://conductscience.org/library/papers/41953014PubMed
41892359Cell-Cell Interactome-Based Pathogenesis and Therapies for Osteosarcoma.Cells2026https://conductscience.org/library/papers/41892359PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41209019

GET https://conductscience.org/api/papers/v1/41209019/references?page=2